Tetra Bio-Pharma Inc. TBPMQ
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -17.55% | -- | -- | -- | -- |
| Total Depreciation and Amortization | 17.77% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 567.28% | -- | -- | -- | -- |
| Change in Net Operating Assets | 382.62% | -- | -- | -- | -- |
| Cash from Operations | 73.37% | -- | -- | -- | -- |
| Capital Expenditure | 96.96% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.49% | -- | -- | -- | -- |
| Cash from Investing | 78.85% | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 27.43% | -- | -- | -- | -- |
| Issuance of Common Stock | -91.64% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.07% | -- | -- | -- | -- |
| Cash from Financing | -97.42% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.52% | -- | -- | -- | -- |